Cargando…
Delayed Injection Site Reaction After mRNA-1273 Vaccination in Japan: A Retrospective, Cross-Sectional Study
The incidence of delayed injection site reaction after the first dose of mRNA-1273 vaccine was 12.5% among females and 1.5% among males in a cohort of primarily elderly Japanese. After the second dose, 48.4% of those who could be contacted reported recurrence. The reaction may be relatively common a...
Autores principales: | Hibino, Masaya, Ishihara, Takuma, Iwata, Mitsunaga, Doi, Yohei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507458/ https://www.ncbi.nlm.nih.gov/pubmed/34651054 http://dx.doi.org/10.1093/ofid/ofab497 |
Ejemplares similares
-
MRNA-1273: Rhabdomyolysis and injection site pain: case report
Publicado: (2021) -
Ulcerative injection site reaction after third COVID‐19 vaccine dose with mRNA‐1273
por: Barei, Francesca, et al.
Publicado: (2022) -
mRNA-1273/tozinameran: Delayed cutaneous reactions: 26 case reports
Publicado: (2021) -
Post-discharge clinical, laboratory and radiographic features of coronavirus disease 2019 (COVID-19) patients at university hospitals in Japan
por: Sasaki, Toshiharu, et al.
Publicado: (2023) -
mRNA-1273: Soreness at the injection site, fatigue and herpes zoster : case report
Publicado: (2021)